Non-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest

Jojanneke Stoof(Cancer Center Amsterdam), Irene V. Bijnsdorp(Amsterdam UMC Location Vrije Universiteit Amsterdam), Sander R. Piersma(Amsterdam UMC Location Vrije Universiteit Amsterdam), Tonny Lagerweij(Amsterdam University Medical Centers), R. Jeroen A. van Moorselaar(Amsterdam UMC Location Vrije Universiteit Amsterdam), Alex A. Henneman(Amsterdam Neuroscience), Marijke Stigter(Cancer Center Amsterdam), Ruud H. Brakenhoff(Dutch Cancer Society), Richard de Goeij-de Haas(Cancer Center Amsterdam), Connie R. Jiménez(Amsterdam UMC Location Vrije Universiteit Amsterdam), Thang V. Pham(Oncode Institute), Zakaria Kalmoua(Cancer Center Amsterdam), Ana Sobota(Eindhoven University of Technology)
Scientific Reports
January 17, 2025
10.1038/s41598-025-85568-0
Cited by 9

Related Papers

The molecular landscape of head and neck cancer
|Nature reviews. Cancer|2018|1.4k
Nontemplated Nucleotide Additions Distinguish the Small RNA Composition in Cells from Exosomes
|Cell Reports|2014|592
Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial
|European Urology|2018|577
Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles
|Journal of Extracellular Vesicles|2021|410
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
|The Lancet Oncology|2012|357